The present invention relates to a sustained-release solid pharmaceuticalformulation comprising (a) an active medicalingredient, (b) a pre-gelatinized starch in an amount of 10 to 90 % by weightbased on the whole weight of the formulationand (c) one or more kinds of enteric ingredients.